Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE-therapeutics Regulatory News (ETX)

Share Price Information for E-therapeutics (ETX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.00
Bid: 9.55
Ask: 10.70
Change: 0.35 (3.63%)
Spread: 1.15 (12.042%)
Open: 9.50
High: 10.00
Low: 9.00
Prev. Close: 9.65
ETX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Results

5 Sep 2017 09:41

RNS Number : 8457P
e-Therapeutics plc
05 September 2017
 

E-THERAPEUTICS PLC

 

("e-therapeutics" or the "Company")

 

Notification of Half Year Results Date

 

Oxford, UK - 5 September 2017 - e-therapeutics plc (AIM: ETX), a company using Network-Driven Drug Discovery (NDD) to create new and better drugs, will announce its half year results for the six months ended 31 July 2017 on Tuesday, 26 September 2017.

 

-Ends-

 

For more information, please contact:

 

e-therapeutics plc

Ray Barlow, Chief Executive Officer

Steve Medlicott, Finance Director

 

Tel: +44 (0) 1993 883 125

www.etherapeutics.co.uk 

 

Numis Securities Limited

Michael Meade/Freddie Barnfield(Corporate Finance)

James Black (Corporate Broking)

 

Tel: +44 (0) 207 260 1000

www.numis.com

 

Instinctif Partners

Melanie Toyne Sewell/Alex Shaw

Tel: +44 (0) 207 457 2020

Email: e-therapeutics@instinctif.com

 

 

 

 

 

 

About e-therapeutics plc

We are an Oxford-based company with a unique and powerful computer-based drug discovery platform and a specialised approach to network biology.

Our novel methodology and our Discovery Engine allow us to discover new and better drugs in a more efficient and effective way.

e-therapeutics is headquartered in Oxford. For more information about the Company please visit www.etherapeutics.co.uk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NORVELBBDKFZBBB
Date   Source Headline
8th Oct 20087:00 amRNSInterim Results
15th Sep 20087:00 amRNSe-Therapeutics partners with KeyGen Biotechnology
4th Sep 20084:35 pmRNSDirectorate Change
21st Jul 20083:42 pmRNSFinal Results
6th May 20087:03 amRNSLaunch of Consultancy Service
4th Apr 20082:38 pmRNSDirector/PDMR Shareholding
5th Feb 200812:02 pmRNSHolding(s) in Company
22nd Jan 20087:01 amRNSETS2101 preclinical progress
10th Dec 200711:18 amRNSPreclinical Update
3rd Dec 20074:58 pmRNSDirector/PDMR Shareholding
28th Nov 20078:00 amRNSFirst day of dealings on AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.